Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

mTNF-PADRE

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Tumor Necrosis Factor-alpha

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
MtNF-YA1, A Central Transcriptional Regulator of Symbiotic Nodule Development, Is Also a Determinant of Medicago truncatula Susceptibility toward a Root Pathogen
Plant NF-Y transcription factors control a wide array of biological functions enabling appropriate reproductive and developmental… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2014
Highly Cited
2014
The CCAAT box-binding transcription factor NF-YA1 controls rhizobial infection
Symbiosis between legume plants and soil rhizobia culminates in the formation of a novel root organ, the ‘nodule’, containing… Expand
  • figure 1
2014
2014
A rice-based soluble form of a murine TNF-specific llama variable domain of heavy-chain antibody suppresses collagen-induced arthritis in mice.
Tumor necrosis factor alpha (TNF) plays a pivotal role in chronic inflammatory diseases such as rheumatoid arthritis and Crohn's… Expand
2014
2014
Exploring Interaction of TNF and Orthopoxviral CrmB Protein by Surface Plasmon Resonance and Free Energy Calculation
Inhibition of the activity of the tumor necrosis factor (TNF) has become the main strategy for treating inflammatory diseases… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
2010
2010
Mutant TNF-alpha, mTNF-K90R, is a novel candidate adjuvant for a mucosal vaccine against HIV.
The development of a safe and effective mucosal vaccine adjuvant is a crucial step for the development of vaccines against human… Expand
2009
2009
The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of mucosal immune responses.
Safe and potent adjuvants are required in order to establish effective mucosal vaccines. Cytokines are promising adjuvants… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2004
Highly Cited
2004
Functionalization of Tumor Necrosis Factor-α Using Phage Display Technique and PEGylation Improves Its Antitumor Therapeutic Window
Purpose: In this study, the optimization of antitumor therapy with tumor necrosis factor-α (TNF-α) was attempted. Experimental… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2002
2002
The transmembrane form of TNF‐α drives autoantibody production in the absence of CD154: studies using MRL/Mp‐Faslpr mice
It is generally accepted that the interaction between CD40 and its ligand (CD154) plays a decisive role in contact‐dependent help… Expand
1997
1997
Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor…
The correlation of persistent tumor necrosis factor-alpha (TNF-alpha) activation with disease progression in patients infected… Expand
1995
1995
Involvement of IFN-gamma in Bacillus Calmette-Guérin-induced but not in tumor-induced sensitization to TNF-induced lethality.
In healthy mice, murine (m) TNF is fairly lethal, whereas human (h) TNF (a selective murine TNF-R55 agonist) is rather harmless… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE